Attached files
| file | filename |
|---|---|
| 10-Q - AOXING PHARMACEUTICAL COMPANY, INC. FORM 10-Q DECEMBER 31, 2010 - AOXING PHARMACEUTICAL COMPANY, INC. | axn10q20101231.htm |
| EX-31.2 - RULE 13A-14(A) CERTIFICATION - CFO - AOXING PHARMACEUTICAL COMPANY, INC. | axn10q20101231ex31-2.htm |
| EX-31.1 - RULE 13A-14(A) CERTIFICATION - CEO - AOXING PHARMACEUTICAL COMPANY, INC. | axn10q20101231ex31-1.htm |
EXHIBIT 32: Rule 13a-14(b) Certification
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Aoxing Pharmaceutical Company, Inc. (the “Company”) certifies that:
1. The Quarterly Report on Form 10-Q of the Company for the period ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
February 14, 2010
|
/s/ Zhenjiang Yue
|
|
Zhenjiang Yue, Chief Executive Officer
|
|
|
|
|
|
February 14, 2010
|
/s/ Bob Ai
|
|
Bob Ai, Chief Financial Officer
|